Marked decrease in specific activity contributes to disease phenotype in two human glucose 6-phosphate dehydrogenase mutants, G6PD(Union) and G6PD(Andalus).
about
What is the role of the second "structural" NADP+-binding site in human glucose 6-phosphate dehydrogenase?A Multi-scale Computational Platform to Mechanistically Assess the Effect of Genetic Variation on Drug Responses in Human Erythrocyte MetabolismAn optimised system for refolding of human glucose 6-phosphate dehydrogenase.The stability of G6PD is affected by mutations with different clinical phenotypes.Coupling between Protein Stability and Catalytic Activity Determines Pathogenicity of G6PD Variants.A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiency.Detailed functional analysis of two clinical glucose-6-phosphate dehydrogenase (G6PD) variants, G6PDViangchan and G6PDViangchan+Mahidol: Decreased stability and catalytic efficiency contribute to the clinical phenotype.Functional and Biochemical Characterization of Three Recombinant Human Glucose-6-Phosphate Dehydrogenase Mutants: Zacatecas, Vanua-Lava and Viangchan.Mutations of Glucose-6-Phosphate Dehydrogenase Durham, Santa-Maria and A+ Variants Are Associated with Loss Functional and Structural Stability of the Protein.Cloning, expression, purification and characterization of his-tagged human glucose-6-phosphate dehydrogenase: a simplified method for protein yield.Biochemical Analysis of Two Single Mutants that Give Rise to a Polymorphic G6PD A-Double Mutant.Biochemical Characterization and Structural Modeling of Fused Glucose-6-Phosphate Dehydrogenase-Phosphogluconolactonase from
P2860
Q28280773-6EFA022A-CB5F-4698-ACF3-32140966FE2CQ28553224-A79AFC2A-F376-4BBF-A7E8-9DD20CFBCA60Q33417901-BD239A99-C272-4C1E-A696-0C83F335E833Q34685681-FCC4397B-9B71-4C69-BEDF-6BC42434B4BFQ38905568-99CE48EF-743D-4BA4-8781-708CC4A05BCFQ38914672-B782A293-56E9-4CB7-B3EF-8653C31CDEB4Q38914675-637F7DAA-E99F-4309-BB5D-A7E79EB15F14Q42759344-2EE06024-D03C-4DA2-8779-4C9D6DDBEBF2Q43116428-1A88A86A-80C6-4AF9-B1DD-B63F3FF7B1C9Q46346066-E65DA444-F100-4A20-BDB5-35D9F015F212Q48050647-D7160C67-BCB9-4EE2-896E-B0E94E41170FQ57167498-45CAB300-2295-427B-8845-644FD064178B
P2860
Marked decrease in specific activity contributes to disease phenotype in two human glucose 6-phosphate dehydrogenase mutants, G6PD(Union) and G6PD(Andalus).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Marked decrease in specific ac ...... G6PD(Union) and G6PD(Andalus).
@en
Marked decrease in specific ac ...... G6PD(Union) and G6PD(Andalus).
@nl
type
label
Marked decrease in specific ac ...... G6PD(Union) and G6PD(Andalus).
@en
Marked decrease in specific ac ...... G6PD(Union) and G6PD(Andalus).
@nl
prefLabel
Marked decrease in specific ac ...... G6PD(Union) and G6PD(Andalus).
@en
Marked decrease in specific ac ...... G6PD(Union) and G6PD(Andalus).
@nl
P2093
P356
P1433
P1476
Marked decrease in specific ac ...... G6PD(Union) and G6PD(Andalus).
@en
P2093
Paul C Engel
Veronica M S Lam
Xiao-Tao Wang
P356
10.1002/HUMU.9367
P577
2005-09-01T00:00:00Z